IVI is uniquely present at every step of the vaccine value chain

ivi-main-program-01
Discover
Develop1
Develop
ivi-img-main-04-img-02
Deliver
백신연구소-메인pic2
Build Capacity

IVI News & Announcements

First ‘Introductory Course for Biologics Development and Manufacturing’ completes training of 106 participants from 24 countries, and 32 Koreans

Call for Applications: 2022 Introductory Training Course for Standard Practice (GxP) organized by the Global Training Hub for Biomanufacturing

IVI and Moderna sign memorandum of understanding for vaccine research and development

The IVI Blog

IVI program in GTH-B | Introductory Course for Biologics Development and Manufacturing

SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea

IVI to operate training courses for WHO global biomanufacturing training hub in Republic of Korea

Global Partners

IVI is uniquely present at every step of the vaccine value chain

ivi-main-mobile-04
Discover
Develop-mobile
Develop
ivi-main-mobile-01
Deliver
Build-Capacity-mobile
Build Capacity

IVI News &
Announcements

First ‘Introductory Course for Biologics Development and Manufacturing’ completes training of 106 participants from 24 countries, and 32 Koreans

Call for Applications: 2022 Introductory Training Course for Standard Practice (GxP) organized by the Global Training Hub for Biomanufacturing

IVI and Moderna sign memorandum of understanding for vaccine research and development

The IVI Blog

IVI program in GTH-B | Introductory Course for Biologics Development and Manufacturing

SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea

IVI to operate training courses for WHO global biomanufacturing training hub in Republic of Korea

Global Partners